PRESS RELEASEREGULATED INFORMATION09 February 2023, 07:00 CEST alfapump® - successful primary endpoint read-out of North American pivotal POSEIDON study / PMA1 filing planned for H2 2023DSR®
PRESS RELEASE Ghent, Belgium - 1 February 2023 - Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver
Sequana Medical announces grant of additional DSR® patent in United States - read this article along with other careers information, tips and advice on BioSpace
Cian Crosbie is no stranger to Ironman triathlon, having completed three full distance events in the last 14 months. However, on Sunday, December 4, he takes on.